Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 2/2004

01-04-2004 | ORIGINAL ARTICLE

Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur

Authors: Masahiko Watanabe, Osamu Nishida, Yasuo Kunii, Susumu Kodaira, Takashi Takahashi, Takeshi Tominaga, Keiichi Hojyo, Tomoyuki Kato, Minoru Niimoto, Kazufumi Kunitomo, Hiroyasu Isomoto, Yasuo Ohashi, Masayuki Yasutomi

Published in: International Journal of Clinical Oncology | Issue 2/2004

Login to get access
Metadata
Title
Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur
Authors
Masahiko Watanabe
Osamu Nishida
Yasuo Kunii
Susumu Kodaira
Takashi Takahashi
Takeshi Tominaga
Keiichi Hojyo
Tomoyuki Kato
Minoru Niimoto
Kazufumi Kunitomo
Hiroyasu Isomoto
Yasuo Ohashi
Masayuki Yasutomi
Publication date
01-04-2004
Publisher
Springer-Verlag
Published in
International Journal of Clinical Oncology / Issue 2/2004
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-003-0374-0

Other articles of this Issue 2/2004

International Journal of Clinical Oncology 2/2004 Go to the issue

ORIGINAL ARTICLE

Phase I/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck

ORIGINAL ARTICLE

Phase I study of CPT-11 and bolus 5-FU/l-leucovorin in patients with metastatic colorectal cancer

ORIGINAL ARTICLE

Gemcitabine plus carboplatin; and gemcitabine, docetaxel, and carboplatin combined chemotherapy regimens in patients with metastatic urothelial carcinoma previously treated with a platinum-based regimen: preliminary report

CASE REPORT

Intraabdominal desmoplastic small round cell tumor: results of ifosfamide-based chemotherapy

REVIEW ARTICLE

The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma

ORIGINAL ARTICLE

Patterns of treatment failure following radiotherapy with combination chemotherapy for patients with high-risk stage IIB cervical carcinoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits